Fuller & Thaler Asset Management, Inc. Alaunos Therapeutics, Inc. Transaction History

Fuller & Thaler Asset Management, Inc.

  • $23.1 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.41 - $1.24 $324,305 - $980,827
-790,990 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$0.62 - $1.17 $1,922 - $3,627
3,100 Added 0.39%
790,990 $516,000
Q4 2021

Feb 09, 2022
BUY
$1.09 - $1.89 $858,800 - $1.49 Million
787,890 New
787,890 $859,000

Others Institutions Holding TCRT

# of Institutions
5
Shares Held
92.6K
Call Options Held
0
Put Options Held
0
View Full List

About Alaunos Therapeutics, Inc.

TCRT Quotes by TradingView
  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $443M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Fuller & Thaler Asset Management, Inc. Portfolio

Follow Fuller & Thaler Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email